4 July 2025 Event Date: 15 September 2025 do: 17 September 2025 •

CTGCT Days 2025 – 15th to 17th September, Ljubljana

REGISTER to join us at CTGCT Days 2025! A 3-day event in Ljubljana, Slovenia, spotlighting breakthroughs in gene & cell therapies (GCT) and their clinical translation. Organised by the Center for the Technologies of Gene and cell Therapy, and opportunity to join 2 conference and attend 2 round tables in a small conference set up with big speakers.

CTGCT Conference – Cell Therapy
(15th-16th September)
with 4 sessions and a round table on Regulatory and Clinical Pathways for GCT

Gene H Conference – Gene Therapy
(17th September)
with 2 sessions and a round table on Bridging Innovation and Commercialization in GCT

Renowned experts in GCT from institutions including University of Rijeka (HR), Masaryk University – Faculty of Medicine – Centre of Excellence CREATIC (CZ), University of Belgrade – Institute of Molecular Genetics and Genetic Engineering – IMGGE (RS), National Institute of Chemistry (SI), UCL (UK), UMC Utrecht (NL), Charité Hospital Berlin (DE) and TU Dresden (DE) will present their latest work. Check the full list below.

Participate with an oral or poster contribution is possible, submit your abstract to this form. If you would like to attend in person or online, REGISTER HERE now (limited spaces).

For more information about the event please check the official CTGCT Days 2025 webpage.

Confirmed speakers

Frank Buchholz

Dean of Research at the Faculty of Medicine Carl Gustav Carus, TU Dresden

Regina Demlová

Head of the Department of Pharmacology at the Masaryk University

Jiri Eitler

Group Leader - NK Cell Immunotherapy at Technische Universität Dresden

Tina Fink

Research Assistant Professor in the Department of Synthetic Biology and Immunology, Kemijski Inštitut

Viktor Glasser

Doctoral Researcher at BeCAT, Charite Berlin

Tanja Jesenko

Senior Scientific Associate at Department of Experimental Onocology, Institut of Oncology Ljubljana

Jürgen Kuball

Professor and Director of the Bone Marrow Transplantation Program at UMC Utrecht

Tina Lebar

Research Assistant Professor in the Department of Synthetic Biology and Immunology, Kemijski Inštitut

Paul Maciocia

Clinical Senior Research Fellow in the Research Department of Haematology, UCL

Natalia Marek-Trzonkowska

Director of the International Centre for Cancer Vaccine Science

Emma Morris

Director, UCL Division of Infection and Immunity Professor of Clinical Cell & Gene Therapy

Damjan Osredkar

Head of the Pediatric Neurology Department at University Medical Centre Ljubljana

Luis Pereira de Almeida

PI of the Gene and Stem Cell Therapies for the Brain group at CNC, University of Coimbra

Matjaž Sever

Medical Doctor at University Clinical Center Ljubljana

James Sleigh

Principal Research Fellow in the Department of Neuromuscular Diseases, UCL

Vesna Spasovski

Assistant Research Professor at IMGGE

Robert Torrance

Last year PhD Student in the Burns/Morris Group, UCL

Felix Wensveen

Professor in the Faculty of Medicine, University of Rijeka

Oscar Wilkings

Research Fellow in RNA in the Department of Neuromuscular Diseases, UCL biology

Robert Zorec

Professor at the Institute of Pathophysiology, University of Ljubljana

Events during the CTGCT 2025 conference

CTGCT conference – Cell therapy

(15th &16th of September)

Focused on developments related to CAR T, other T cell therapies and solid cancer tumors together with a session specifically focused on the translation aspect of gene and cell therapies.

Round Table I – Regulatory and Clinical Pathways for Gene and Cell Therapy

(16th of September)

It will explore the regulatory and clinical frameworks guiding the development and approval of gene and cell therapies with participations from expert from both Slovenia and abroad.

Gene H Conference – Gene Therapy

(17th of September)

Renown experts in the Gene therapy field with a focus on rare diseases will present innovations on delivery systems and other advances beyond CRISPR.

Round Table II – Bridging Innovation and Commercialization in Gene and Cell Therapy